Delivery Order SPE2DB22D3011-SPE2DB25FQ0FF

Award Date 4/4/25
Potential Completion Date 4/7/25
Potential Value $23K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Mesalamine 800 mg delayed-release tablets, with a ceiling value of $11,775.90 and a performance period through January 2, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,032.04, is for the supply of 4,564,460,385 units of the pharmaceutical product Mesalamine DR 1.2 GM Tablet 120S. The contract has a firm fixed price pricing type and an ultimate completion date of May 2, 2024. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,173.18 firm fixed-price contract is for the supply of Mesalamine 800 mg delayed-release tablets to support military healthcare programs. The contract has an ultimate completion date of February 2, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,913.57, is for the supply of Mesalamine 800 mg delayed-release tablets to support federal healthcare programs. This is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,178.58, is for the delivery of 120 tablets of the pharmaceutical product Mesalamine DR 1.2 GM. The contract has a completion date of February 26, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $10,442.89 contract is for the delivery of Mesalamine 800 mg delayed-release tablets. The contract is a firm fixed-price type with an ultimate completion date of October 25, 2022. This award is not associated with a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract with DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Mesalamine delayed-release tablets. The contract has a ceiling value of $2,093.71 and runs through April 27, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of...
This is a federal contract award by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $17,541.47, is for the delivery of Mesalamine 800 mg delayed-release tablets. This award is a delivery order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,453.14, is for the supply of MESALAMINE DR 1.2 GM TABLET 120S, a generic pharmaceutical product. The contract has a completion date of June 14, 2024, and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,362.00, is for the delivery of 180 counts of 800 mg Mesalamine delayed-release tablets. The contract has a completion date of November 6, 2024 and is a firm fixed-price delivery order. The contract was not set aside for any specific business category....
  • SPE2DB22D3011
    Indefinite Delivery Contract
  • SPE2DB22D3011-SPE2DB25FQ0FF
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Mesalamine 800 mg delayed-release (DR) tablets in quantities of 180 per bottle. The contract has a ceiling value of $23,284.65 and runs through April 7, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 7/4/25, 11:12 AM